Search Results
May 21, 2026, 17:17 ET Rigel Announces Oral and Poster Presentations at the 2026 ASCO Annual Meeting and EHA2026 Congress
poster sessionReal-world data further supports the use of REZLIDHIA® (olutasidenib) in patients with R/R mIDH1 AML that have received prior venetoclaxSOUTH SAN FRANCISCO, Calif., May
More news about: Rigel Pharmaceuticals, Inc.
May 21, 2026, 17:00 ET Sapience Therapeutics Provides Positive Data Update from Phase 2 Trial of Lucicebtide Plus SOC in Patients with Glioblastoma at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting
PMID: 38994023; PMCID: PMC11234274.4 Stupp, R., et al., Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med, 2005. DOI: 10.1056/NEJMoa043330.PMID: 157580095 Stupp R, Taillibert S, Kanner A, et al. Effect of Tumor-Treating Fields
More news about: Sapience Therapeutics, Inc.
May 21, 2026, 17:00 ET Servier Presentations at ASCO 2026 Spotlight Expanding Rare Oncology Portfolio
to offer targeted therapeutic solutions, particularly in rare cancers and neurological diseases, and invests nearly 20% of its brand-name sales in R&D.Headquartered in France, Servier relies on its more than 20,000 employees and a solid geographic presence with medicines distributed in more
More news about: Servier Pharmaceuticals
May 21, 2026, 17:00 ET New Clinical Data for Izalontamab Brengitecan and Novel ADC Pipeline to be Presented at ASCO 2026
China)Session Date & Time: Monday, June 1st, 2026, 8:00 AM-11:00 AM CDTT-Bren (BL-M07D1) in patients with recurrent or metastatic (R/M) ovarian cancer: Results from two phase II studiesTrial Reference: BL-M07D1-202/203 (NCT06031584/NCT06131450), China Session
More news about: SystImmune, Inc.
May 21, 2026, 17:00 ET Lilly to showcase oncology portfolio across tumor types and treatment modalities at the 2026 American Society of Clinical Oncology Annual Meeting
small lymphocytic lymphoma (CLL/SLL) who have previously been treated with a covalent BTK inhibitor.Adult patients with relapsed or refractory (R/R) mantle cell lymphoma (MCL) after at least two lines of systemic therapy, including a BTK inhibitor. This indication is approved under accelerated approval
More news about: Eli Lilly and Company
May 21, 2026, 16:54 ET Positive topline results from the pivotal Phase 3 REDUCE 2 study of pozdeutinurad in gout
very encouraged by these results and their implications for patients whose gout remains inadequately controlled," said Lydia Abad-Franch, MD, Head of R&D and Medical Affairs and Chief Medical Officer at Sobi. "These findings, including sustained urate lowering and a favourable efficacy and tolerability
More news about: Swedish Orphan Biotrauma AB
May 21, 2026, 16:51 ET Positive topline results from the pivotal Phase 3 REDUCE 2 study of pozdeutinurad in gout
very encouraged by these results and their implications for patients whose gout remains inadequately controlled," said Lydia Abad-Franch, MD, Head of R&D and Medical Affairs and Chief Medical Officer at Sobi. "These findings, including sustained urate lowering and a favourable efficacy and tolerability
More news about: Swedish Orphan Biotrauma AB
May 21, 2026, 16:05 ET FLOWERS FOODS, INC. REPORTS FIRST QUARTER 2026 RESULTS
interruptions, intrusions, cyber-attacks or security breaches of such systems or risks associated with the implementation of the upgrade of our ERP system; and (r) the potential impact of climate change on the company, including physical and transition risks, our availability or restriction of resources, higher
More news about: Flowers Foods, Inc.
May 21, 2026, 15:49 ET Electrolux Group announces terms for the fully underwritten rights issue of SEK 9,062 million
https://news.cision.com/electrolux-group/r/electrolux-group-announces-terms-for-the-fully-underwritten-rights-issue-of-sek-9-062-million,c4351800The following files are available for download:
More news about: Electrolux Group
May 21, 2026, 15:45 ET Electrolux Group announces terms for the fully underwritten rights issue of SEK 9,062 million
https://news.cision.com/electrolux-group/r/electrolux-group-announces-terms-for-the-fully-underwritten-rights-issue-of-sek-9-062-million,c4351800The following files are available for download:
More news about: Electrolux Group
May 21, 2026, 15:40 ET LKQ Corporation (LKQ) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
in some jurisdictions under the applicable law and ethical rules.Contact Us:The Law Offices of Frank R. Cruz, Los AngelesFrank R. Cruz, Telephone: 310-914-5007Email: [email protected]
More news about: Law Offices of Howard G. Smith
May 21, 2026, 15:15 ET Greenberg Traurig Strengthens SALT Practice with John Ormonde in Washington, D.C.
Bradley R. Marsh, co-chair of Greenberg Traurig's U.S. SALT Practice. "He combines strong technical knowledge with a practical, business-minded perspective,
More news about: Greenberg Traurig, LLP
May 21, 2026, 15:10 ET Pomerantz Law Firm Announces the Filing of a Class Action Against Regencell Bioscience Holdings Limited and Certain Officers - RGC
incurable, the Company's research and development ("R&D") costs were only $0.95 million and $1.07 million for the years ended June 30, 2025 and 2024, respectively. This stands in stark contrast with Regencell's own representations that "[a]verage [R&D] to marketplace cost for a new medicine is nearly
More news about: Pomerantz LLP
May 21, 2026, 15:10 ET Pomerantz Law Firm Announces the Filing of a Class Action Against Babcock & Wilcox Enterprises, Inc. and Certain Officers - BW
Group Holdings, Inc. ("BRC"), formerly B. Riley Financial, Inc. BRC's Co-Chief Operating Officer ("CEO") and Chairman of its Board of Directors is Bryant R. Riley ("Riley").On November 4, 2025, B&W announced its entry into an agreement for a limited notice to proceed—that is, a preliminary agreement
More news about: Pomerantz LLP
May 21, 2026, 14:03 ET New research shows how snacking on almonds improves diets
1 Maillot M, Poinsot R, Tahiri M, Drewnowski A. Replacing Solid Snacks with Almonds or Adding Almonds to the Diet Improves Diet Quality and Compliance with the 2020-25
More news about: Almond Board of California
May 21, 2026, 13:32 ET PHAI's Dr. Harry Levant Testifies Before U.S. Senate, Urging Federal Action on Sports Betting
At the hearing, No Sure Bets: Protecting Sports Integrity in America, convened by U.S. Senator Marsha Blackburn (R-Tenn.), Chair of the Senate subcommittee, sought to bring together a range of perspectives to examine the impact of the rapid expansion of sports betting
More news about: Public Health Advocacy Institute
May 21, 2026, 13:16 ET Silicon Photonics Market Size Forecast at USD 9.6 Billion by 2030 | Wissen Research
identify new growth opportunities across global marketsCompany Contact:Wissen Research LLC,Gould St, Ste R,Sheridan, WY 82801,Phone: (+1) 510 240 9853Email: [email protected]
More news about: Wissen Research LLC
May 21, 2026, 12:36 ET /C O R R E C T I O N -- AARP Pennsylvania/
More news about: AARP Pennsylvania
May 21, 2026, 12:34 ET Successful first flight of the world's first Unmanned Airborne Early Warning solution
sensing to defend against tactical air munitions, guided missiles, drones, fighter and bomber aircraft, and other threats," said GA-ASI President David R. Alexander. "Operational availability for a medium-altitude, long-endurance UAS is the highest of any military aircraft, and as an unmanned platform,
More news about: Saab
May 21, 2026, 11:48 ET Outcomes4Me Acquires Geno.Me and Realyze Intelligence, Names UPMC Hillman Cancer Center CIO as Strategic Advisor, to Expedite AI-driven Cancer Care and Clinical Trial Access
structured clinical data models, along with rapid clinical trial matching, supercharges our ability to support patients living with cancer," said Maya R. Said, Sc.D., Founder and CEO of Outcomes4Me. "It also deepens our ability to help our commercial partners with both clinical trial recruitment and better
More news about: Outcomes4Me Inc.
May 21, 2026, 11:21 ET MAHA Action Backs President Trump's Call to Pass Railway Safety Act as Critical House Committee Vote Hits Today
living near a rail line deserves. There is no excuse for delay."The Railway Safety Act, H.R. 7748, was reintroduced this year by Sen. Jon Husted (R-OH) in the Senate and Rep. Chris Deluzio (D-PA) in the House. The bill addresses the specific failures that produced the East Palestine catastrophe, including:
More news about: MAHA Action